INVES 21

Trend of Stock Market

A trend is the broad upward or downward movement of a stock's price over time

Forthcoming IPO Open Issues Closed Issue
Forthcoming Issues Open Issues Closed Issue
World Indices ADR Prices MF Investment FII Investment
Get Quotes Company Snapshot Company Background Board of Directors Directors Reports Profit & Loss Balance Sheet Quarterly Results Shareholding Pattern Key Financial Ratios Mutual Fund Holdings Peer Comparison Technical Chart

Profit & Loss

Change Company Name

Zydus Lifesciences Ltd

Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code 532321	ISIN Demat INE010B01027	Book Value 210.59	NSE Symbol ZYDUSLIFE	Dividend Yield (%) 1.15	Market Cap (₹ Cr.) 96,568.28	P/E 16.8	EPS 57.12	Face Value 1

Particulars (₹ Cr)	Mar2025	Mar2024	Mar2023	Mar2022	Mar2021
Revenue From Operations	15,116.30	10,818.70	8,731.60	7,836.90	7,780.00
Sale of Products	14,590.10	10,317.60	8,421.20	7,590.00	7,436.70
Sale of Services	0.00	0.00	0.00	0.00	0.00
Income from Investment and Financial Services	0.00	0.00	0.00	0.00	0.00
Income from Insurance Operations	0.00	0.00	0.00	0.00	0.00
Other Operating Revenue	526.20	501.10	310.40	246.90	343.30
Less: Excise Duty / GST	0.00	0.00	0.00	0.00	0.00
Revenue From Operations - Net	15,116.30	10,818.70	8,731.60	7,836.90	7,780.00
Other Income	696.20	1,084.80	548.40	178.70	89.30
Total Revenue	15,812.50	11,903.50	9,280.00	8,015.60	7,869.30
Changes in Inventories	-121.10	-131.70	105.10	-46.90	-148.30
Cost of Material Consumed	2,787.10	3,001.40	2,703.50	2,629.00	2,346.40
Internally Manufactured Intermediates Consumed	0.00	0.00	0.00	0.00	0.00
Purchases of Stock-in-Trade	350.90	283.20	362.70	288.10	153.30
Employee Benefits	1,762.20	1,507.50	1,321.90	1,204.90	1,147.30
Total Other Expenses	2,600.90	2,099.60	1,784.00	1,843.70	1,972.60
Manufacturing / Operating Expenses	725.90	645.40	611.10	626.30	556.60
Administrative and Selling Expenses	1,384.00	1,017.80	1,039.80	958.40	1,009.10
Other Expenses	491.00	436.40	133.10	259.00	406.90
Finance Costs	463.90	390.70	278.20	134.90	70.90
Depreciation and Amortization	523.90	504.40	488.60	478.70	451.10
Total Expenses	8,367.80	7,655.10	7,044.00	6,532.40	5,993.30
Profit Before Exceptional Items and Tax	7,444.70	4,248.40	2,236.00	1,483.20	1,876.00
Exceptional Items Before Tax	0.00	-8.60	-203.80	-319.30	-187.50
Profit Before Extraordinary Items and Tax	7,444.70	4,239.80	2,032.20	1,163.90	1,688.50
Extraordinary Items Before Tax	0.00	0.00	0.00	0.00	0.00
Other Adjustments Before Tax	0.00	0.00	0.00	0.00	0.00
Profit Before Tax	7,444.70	4,239.80	2,032.20	1,163.90	1,688.50
Taxation	1,669.80	798.30	503.00	306.00	212.30
Current Tax	1,513.00	934.30	464.10	260.20	303.20
MAT Credit Entitlement	0.00	0.00	0.00	0.00	0.00
Deferred Tax	87.30	-136.00	41.20	45.80	-91.00
Other Tax	0.00	0.00	0.00	0.00	0.00
Adjust for Previous Year	69.50	0.00	-2.30	0.00	0.10
Profit After Tax	5,774.90	3,441.50	1,529.20	857.90	1,476.20
Extraordinary Items After Tax	0.00	0.00	0.00	0.00	0.00
Discontinued Operations After Tax	0.00	0.00	0.00	0.00	0.00
Profit / (Loss) from Discontinuing Operations	0.00	0.00	0.00	0.00	0.00
Tax Expenses of Discontinuing Operations	0.00	0.00	0.00	0.00	0.00
Profit Attributable to Shareholders	5,774.90	3,441.50	1,529.20	857.90	1,476.20
Adjustments to Net Income	0.00	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00
Profit Attributable to Equity Shareholders	5,774.90	3,441.50	1,529.20	857.90	1,476.20
Earning Per Share - Basic	57.39	34.01	15.06	8.38	14.42
Earning Per Share - Diluted	57.39	34.01	15.06	8.38	14.42
Operation Profit before Depreciation	8,432.50	5,143.50	3,002.80	2,096.80	2,398.00
Operating Profit after Depreciation	7,908.60	4,639.10	2,514.20	1,618.10	1,946.90
Dividend Per Share	11.00	3.00	6.00	2.50	3.50
Dividend Percentage	1,100.00	300.00	600.00	250.00	350.00
Equity Dividend	1,106.86	301.87	607.32	255.94	358.31
Weighted Average Shares - Basic	100.62	101.19	101.56	102.37	102.37
Weighted Average Shares - Diluted	100.62	101.19	101.56	102.37	102.37